$AQMS
Aqua Metals, Inc. Stock $aqms

$aqms Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000143774921004116 Filed on February 25, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2019 Q3
Revenue	$0.00	$593.0K	$2.361M
YoY Change	-100.0%	-44.63%	101.97%
Cost Of Revenue	$1.081M	$4.702M	$8.231M
YoY Change	-77.01%	-25.03%	27.55%
Gross Profit	-$1.081M	-$4.109M	-$5.870M
YoY Change	-73.69%	-21.0%	11.09%
Gross Profit Margin		-692.92%	-248.62%
Selling, General & Admin	$3.010M	$6.140M	$5.360M
YoY Change	-50.98%	-14.84%	71.79%
% of Gross Profit
Research & Development	$358.0K	$315.0K	$282.0K
YoY Change	13.65%	-63.24%	-70.84%
% of Gross Profit
Depreciation & Amortization	$430.0K	$950.0K	$900.0K
YoY Change	-54.74%	4.4%	12.5%
% of Gross Profit
Operating Expenses	$358.0K	$315.0K	$13.62M
YoY Change	13.65%	-97.66%	41.96%
Operating Profit	-$4.151M	-$10.28M	-$11.26M
YoY Change	-59.62%	-17.16%	33.64%
Interest Expense	$1.107M	$243.0K	$142.0K
YoY Change	355.56%	-80.11%	-84.55%
% of Operating Profit
Other Income/Expense, Net	-$11.36M	-$990.0K	-$57.00K
YoY Change	1047.88%	-11.76%	-93.2%
Pretax Income	-$15.52M	-$11.27M	-$11.32M
YoY Change	37.67%	-16.72%	22.16%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$15.52M	-$11.27M	-$11.32M
YoY Change	37.67%	-16.72%	22.16%
Net Earnings / Revenue		-1900.51%	-479.29%
Basic Earnings Per Share
Diluted Earnings Per Share	-$247.4K	-$195.7K	-$198.4K
COMMON SHARES
Basic Shares Outstanding	61.18M	57.39M shares	56.96M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.530M	$7.580M	$15.54M
YoY Change	-13.85%	-63.71%	-45.99%
Cash & Equivalents	$6.533M	$7.575M	$15.54M
Short-Term Investments
Other Short-Term Assets	$700.0K	$18.43M	$880.0K
YoY Change	-96.2%		175.0%
Inventory	$1.091M	$1.257M	$1.823M
Prepaid Expenses
Receivables	$32.00K	$244.0K	$1.714M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.358M	$27.50M	$19.95M
YoY Change	-69.61%	20.88%	-35.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$24.88M	$37.64M	$51.65M
YoY Change	-33.9%	-17.36%	11.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.078M	$3.309M	$4.273M
YoY Change	-67.42%	83.83%	172.17%
Total Long-Term Assets	$26.78M	$41.95M	$56.97M
YoY Change	-36.16%	-13.71%	15.53%
TOTAL ASSETS
Total Short-Term Assets	$8.358M	$27.50M	$19.95M
Total Long-Term Assets	$26.78M	$41.95M	$56.97M
Total Assets	$35.14M	$69.45M	$76.92M
YoY Change	-49.41%	-2.69%	-4.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.552M	$4.829M	$5.288M
YoY Change	-67.86%	131.27%	182.78%
Accrued Expenses	$1.253M	$4.133M	$3.582M
YoY Change	-69.68%	-20.46%	77.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.00K	$300.0K	$280.0K
YoY Change	-86.67%	-93.17%	-91.64%
Total Short-Term Liabilities	$3.454M	$9.810M	$9.683M
YoY Change	-64.79%	-16.86%	29.97%
LONG-TERM LIABILITIES
Long-Term Debt	$320.0K	$8.430M	$8.520M
YoY Change	-96.2%	-1.98%	-1.73%
Other Long-Term Liabilities	$220.0K	$1.630M	$1.760M
YoY Change	-86.5%	85.23%	27.54%
Total Long-Term Liabilities	$540.0K	$10.06M	$10.28M
YoY Change	-94.63%	6.12%	2.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.454M	$9.810M	$9.683M
Total Long-Term Liabilities	$540.0K	$10.06M	$10.28M
Total Liabilities	$3.999M	$19.87M	$19.96M
YoY Change	-79.87%	-6.65%	14.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$165.7M	-$139.9M	-$128.6M
YoY Change	18.42%	47.11%
Common Stock	$196.8M	$189.5M	$185.6M
YoY Change	3.86%	30.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.14M	$49.59M	$56.97M
YoY Change
Total Liabilities & Shareholders Equity	$35.14M	$69.45M	$76.92M
YoY Change	-49.41%	-2.69%	-4.27%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	-$15.52M	-$11.27M	-$11.32M
YoY Change	37.67%	-16.72%	22.16%
Depreciation, Depletion And Amortization	$430.0K	$950.0K	$900.0K
YoY Change	-54.74%	4.4%	12.5%
Cash From Operating Activities	-$2.040M	-$6.590M	-$6.760M
YoY Change	-69.04%	-4.91%	-6.24%
INVESTING ACTIVITIES
Capital Expenditures	-$360.0K	-$4.650M	-$4.950M
YoY Change	-92.26%	638.1%	638.81%
Acquisitions
YoY Change
Other Investing Activities	$40.00K	$3.350M	-$20.00K
YoY Change	-98.81%	-1556.52%	100.0%
Cash From Investing Activities	-$330.0K	-$1.300M	-$4.970M
YoY Change	-74.62%	51.16%	630.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.260M	-80.00K	-40.00K
YoY Change	-4175.0%	-11.11%	-60.0%
NET CHANGE
Cash From Operating Activities	-2.040M	-6.590M	-6.760M
Cash From Investing Activities	-330.0K	-1.300M	-4.970M
Cash From Financing Activities	3.260M	-80.00K	-40.00K
Net Change In Cash	890.0K	-7.970M	-11.77M
YoY Change	-111.17%	1.14%	47.31%
FREE CASH FLOW
Cash From Operating Activities	-$2.040M	-$6.590M	-$6.760M
Capital Expenditures	-$360.0K	-$4.650M	-$4.950M
Free Cash Flow	-$1.680M	-$1.940M	-$1.810M
YoY Change	-13.4%	-69.21%	-72.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	67139664
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64461065
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64461065
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57997780
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57997780
CY2020Q4	aqms	Number Of Subsidiaries NumberOfSubsidiaries	2	pure
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2020	aqms	Number Of Geographic Segments NumberOfGeographicSegments	1	pure
CY2019	aqms	Percentage Of Revenue From Products Transferred At Point In Time PercentageOfRevenueFromProductsTransferredAtPointInTime	1	pure
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2020Q4	aqms	Lessee Finance Lease Number Of Leases LesseeFinanceLeaseNumberOfLeases	1	pure
CY2020Q4	aqms	Lessee Operating Lease Number Of Leases LesseeOperatingLeaseNumberOfLeases	2	pure
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	600000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6533000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5780000	USD
CY2019Q4	aqms	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	861000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7575000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	244000	USD
CY2020Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	0	USD
CY2019Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	17446000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1091000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1257000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	702000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	981000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	8358000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	27503000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24883000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37643000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	819000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	999000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1078000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3309000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	26780000	USD
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	41951000	USD
CY2020Q4	us-gaap	Assets Assets	35138000	USD
CY2019Q4	us-gaap	Assets Assets	69454000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1552000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4829000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1253000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4133000	USD
CY2020Q4	aqms	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	620000	USD
CY2019Q4	aqms	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	552000	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	29000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	296000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3454000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9810000	USD
CY2020Q4	aqms	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	242000	USD
CY2020Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	0	USD
CY2019Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	790000	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	303000	USD
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	8404000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	3999000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	19865000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	64000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	196728000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	189422000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165653000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-139891000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	31139000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	49589000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35138000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69454000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	108000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4874000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5476000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24799000	USD
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1027000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	49589000	USD
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	48000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5780000	USD
CY2019	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4927000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1620000	USD
CY2019	us-gaap	Interest Expense InterestExpense	3477000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-44795000	USD
CY2019	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1555000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8998000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19314000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	15501000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	45668000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-15393000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-40794000	USD
CY2020	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	2946000	USD
CY2019	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	-792000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	11741000	USD
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	-0	USD
CY2019	us-gaap	Interest And Other Income InterestAndOtherIncome	270000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10367000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3999000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25760000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44793000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25762000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-44795000	USD
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60861450
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52263885
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	50090000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4206000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3569000	USD
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	64000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25762000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	31139000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25762000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-44795000	USD
CY2020	aqms	Depreciation And Right Of Use Asset Amortization DepreciationAndRightOfUseAssetAmortization	2231000	USD
CY2019	aqms	Depreciation And Right Of Use Asset Amortization DepreciationAndRightOfUseAssetAmortization	3899000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	180000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	182000	USD
CY2020	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	45000	USD
CY2019	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	46000	USD
CY2020	aqms	Fair Value Of Common Stock Issued For Consulting Services FairValueOfCommonStockIssuedForConsultingServices	64000	USD
CY2019	aqms	Fair Value Of Common Stock Issued For Consulting Services FairValueOfCommonStockIssuedForConsultingServices	4925000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	3572000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	4206000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	607000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	56000	USD
CY2020	aqms	Noncash Convertible Note Interest Expense NoncashConvertibleNoteInterestExpense	0	USD
CY2019	aqms	Noncash Convertible Note Interest Expense NoncashConvertibleNoteInterestExpense	2556000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-149000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	11741000	USD
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	521000	USD
CY2019	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	0	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-212000	USD
CY2020	aqms	Payments To Acquire Equipment Deposits And Other Assets PaymentsToAcquireEquipmentDepositsAndOtherAssets	4000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-481000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-166000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	492000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-280000	USD
CY2019	aqms	Payments To Acquire Equipment Deposits And Other Assets PaymentsToAcquireEquipmentDepositsAndOtherAssets	272000	USD
CY2020	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	9838000	USD
CY2019	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2500000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6633000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10574000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3676000	USD
CY2020	aqms	Noncash Interest Expense NoncashInterestExpense	0	USD
CY2019	aqms	Noncash Interest Expense NoncashInterestExpense	95000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	90000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-90000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	612000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1999000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	823000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2448000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2031000	USD
CY2020	aqms	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0	USD
CY2019	aqms	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-35000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	528000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	500000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11028000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25177000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3363000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12802000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	162000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	29380000	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	332000	USD
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	654000	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	295000	USD
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	USD
CY2019	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	6651000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3354000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22434000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1041000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13317000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7575000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20892000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6534000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7575000	USD
CY2020	us-gaap	Interest Paid InterestPaid	1044000	USD
CY2019	us-gaap	Interest Paid InterestPaid	697000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	2000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	2000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	64000	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	4925000	USD
CY2020	aqms	Change In Property And Equipment Resulting From Change In Accounts Payable ChangeInPropertyAndEquipmentResultingFromChangeInAccountsPayable	1280000	USD
CY2019	aqms	Change In Property And Equipment Resulting From Change In Accounts Payable ChangeInPropertyAndEquipmentResultingFromChangeInAccountsPayable	-1921000	USD
CY2020	aqms	Change In Property And Equipment Resulting From Change In Accrued Expenses ChangeInPropertyAndEquipmentResultingFromChangeInAccruedExpenses	431000	USD
CY2019	aqms	Change In Property And Equipment Resulting From Change In Accrued Expenses ChangeInPropertyAndEquipmentResultingFromChangeInAccruedExpenses	-928000	USD
CY2020	aqms	Change In Equity Resulting From Change In Accrued Expenses ChangeInEquityResultingFromChangeInAccruedExpenses	24000	USD
CY2019	aqms	Change In Equity Resulting From Change In Accrued Expenses ChangeInEquityResultingFromChangeInAccruedExpenses	1300000	USD
CY2020	aqms	Change In Property And Equipment Resulting From Fire Damaged Assets Written Off ChangeInPropertyAndEquipmentResultingFromFireDamagedAssetsWrittenOff	0	USD
CY2019	aqms	Change In Property And Equipment Resulting From Fire Damaged Assets Written Off ChangeInPropertyAndEquipmentResultingFromFireDamagedAssetsWrittenOff	-19946000	USD
CY2020	aqms	Change In Insurance Proceeds Receivable ChangeInInsuranceProceedsReceivable	0	USD
CY2019	aqms	Change In Insurance Proceeds Receivable ChangeInInsuranceProceedsReceivable	17446000	USD
CY2020	aqms	Change In Other Assets To Extinguish Notes Payable ChangeInOtherAssetsToExtinguishNotesPayable	8653000	USD
CY2019	aqms	Change In Other Assets To Extinguish Notes Payable ChangeInOtherAssetsToExtinguishNotesPayable	0	USD
CY2020	aqms	Change In Accounts Receivable Resulting From Insurance Funds Held In Escrow ChangeInAccountsReceivableResultingFromInsuranceFundsHeldInEscrow	7938000	USD
CY2019	aqms	Change In Accounts Receivable Resulting From Insurance Funds Held In Escrow ChangeInAccountsReceivableResultingFromInsuranceFundsHeldInEscrow	0	USD
CY2020	us-gaap	Nature Of Operations NatureOfOperations	<table border="0" cellpadding="0" cellspacing="0" style="width:29.6%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;"><tbody><tr><td colspan="1" style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 10%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><em style="font: inherit;">1.</em></p> </td><td colspan="1" style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 90%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Organization and Operations</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Aqua Metals, Inc. (the “Company”) was incorporated in Delaware and commenced operations on <em style="font: inherit;"> June 20, 2014 (</em>inception). On <em style="font: inherit;"> January 27, 2015, </em>the Company formed <span style="-sec-ix-hidden:c69626992">two</span> wholly-owned subsidiaries, Aqua Metals Reno, Inc. (“AMR”) and Aqua Metals Operations, Inc. (collectively, the “Subsidiaries”), both incorporated in Delaware. The Company is engaged in the business of equipment supply, technology licensing and related services for recycling lead through a novel, proprietary and patented process the Company developed and named AquaRefining™. Prior to <em style="font: inherit;"> November 29, 2019, </em>the Company was engaged in the business of lead recycling through its patented and patent-pending AquaRefining technology. Following a fire at its lead recycling facility on <em style="font: inherit;"> November 29, 2019, </em>the Company's business model has transitioned to a focus on global licensing opportunities to incorporate AquaRefining in the recycling industry. </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Unlike smelting, AquaRefining is a room temperature, water-based process that emits less pollution than smelting, the traditional method of lead recycling. The Company built its recycling facility in Nevada’s Tahoe Reno Industrial Center (“TRIC”) in McCarran, Nevada. The Company commenced the shipment of products for sale, consisting of lead compounds and plastics in <em style="font: inherit;"> April 2017, </em>and through <em style="font: inherit;"> March 31, 2018 </em>substantially all revenue was derived from the sale of lead compounds and plastics. In <em style="font: inherit;"> April 2018, </em>the Company commenced the limited production of lead bullion, including AquaRefined lead. In <em style="font: inherit;"> July 2018, </em>the Company commenced the sale of pure AquaRefined lead in the form of <em style="font: inherit;">two</em> tonne blocks and in <em style="font: inherit;"> October 2018, </em>the Company commenced the sale of AquaRefined lead in the form of battery manufacturing ready ingots. In <em style="font: inherit;"> November 2018, </em>the Company received official vendor certification from Clarios for its AquaRefined lead and, in <em style="font: inherit;"> December 2018, </em>the Company commenced shipments directly to Clarios owned and partner battery manufacturing facilities. In <em style="font: inherit;">2019,</em> the Company operated its demonstration AquaRefinery at commercial quantity production levels and produced over <em style="font: inherit;">35,000</em> AquaRefined ingots by operating the AquaRefinery <em style="font: inherit;">24</em> hours a day and <em style="font: inherit;">seven</em> days a week for sustained periods of time. The AquaRefining Aqualyzers produced at or above the target <em style="font: inherit;">100</em> Kg/Hr of production throughput per module of <em style="font: inherit;">six</em> Aqualyzers or ~ <em style="font: inherit;">16</em>-<em style="font: inherit;">17</em> Kg/Hr per Aqualyzer and ran sustained endurance runs for over <em style="font: inherit;">one</em> month several times.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the <em style="font: inherit;">first</em> half of <em style="font: inherit;">2020,</em> the Company successfully performed test runs on the <em style="font: inherit;">first</em> and <em style="font: inherit;">second</em> iterations of its Aqualyzer as part of the <em style="font: inherit;">V1.25L</em> program. The program consists of <em style="font: inherit;">three</em> iterations that are classified as <em style="font: inherit;">V1.25a,</em> <em style="font: inherit;">V1.25b</em> and the final iteration, <em style="font: inherit;">V1.25L,</em> the latter of which will be used to create the AquaRefining Aqualyzer package for equipment supply and licensing offerings. In <em style="font: inherit;"> December, 2020, </em>Aqua Metals completed the <em style="font: inherit;">V1.25L</em> Aqualyzer program on time and under budget, achieving lead production that is <em style="font: inherit;">100%</em> greater than the <em style="font: inherit;">V1.0</em> Aqualyzer deployed at the AquaRefinery during commercial production in <em style="font: inherit;">2018</em> and <em style="font: inherit;">2019.</em> The <em style="font: inherit;">V1.25L</em> program concluded with a multi-day <em style="font: inherit;">24/7</em> endurance run that ended on <em style="font: inherit;"> December 24</em><sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>. The doubling of throughput results in a <em style="font: inherit;">50%</em> reduction in the number of Aqualyzers needed for equivalent lead production.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Liquidity and Management Plans</span></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: justify; text-indent: 27pt;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company generated revenues of $0.1 million and $4.9 million during the years ended <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;"> December 31, 2019</em>, respectively. The Company had net losses of $25.8 million and $44.8 million for the years ended <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;"> December 31, 2019</em>, respectively. As of <em style="font: inherit;"> December 31, 2020</em>, the Company’s cash balance was $6.5 million. As of the date of this report, the Company believes it <em style="font: inherit;"> may </em>require additional capital, in order to fund its current level of ongoing costs over the next <em style="font: inherit;">twelve</em> months and move forward with its capital light licensing strategy.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/>
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	100000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4900000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-44800000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6500000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Use of estimates</span></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:29.25pt;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of expenses during the period. Significant items subject to such estimates and assumptions include the carrying amount and valuation of long-lived assets, valuation allowances for deferred tax assets, the determination of fair value of estimated asset retirement obligations, the determination of stock option expense and the determination of the fair value of stock warrants issued. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:29.25pt;"> </p>
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	11700000	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7115339
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8529231
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><span style="text-decoration: underline; ">Concentration of Credit Risk</span></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:31.5pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Revenues from the following customers each represented at least <em style="font: inherit;">10%</em> of total revenue for the years ended <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;"> December 31, 2019</em>. The Company did <span style="-sec-ix-hidden:c69627126">not</span> have an accounts receivable (trade) balance as of <em style="font: inherit;"> December 31, 2020</em>. Clarios represented all of our accounts receivable (trade) balance as of <em style="font: inherit;"> December 31, 2019</em>. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;"><em style="font: inherit;">Accounts Receivable (Trade)</em></em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;"><em style="font: inherit;">Revenue</em></em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;"><em style="font: inherit;">As of December 31,</em></em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">2020</em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">2019</em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">2020</em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">2019</em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Clarios (successor of Johnson Controls Battery Group, Inc.)</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">16</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">69</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">100</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">P. Kay Metals</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">84</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">28</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Substantially all of the chemicals used in our refining process has been provided by one supplier. Historically, the supply of used lead acid batteries has been provided by two vendors. The Company did <em style="font: inherit;">not</em> purchase any used lead acid batteries during the year ended <em style="font: inherit;"> December 31, 2020</em>. The table below indicates the percentage of used batteries provide by our <em style="font: inherit;">two</em> primary suppliers during the years ended <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;"> December 31, 2019</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">2020</em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">2019</em></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 74%;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Supplier A</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">69</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Supplier B</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">30</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p>
CY2020	aqms	Percentage Of Revenue From Products Transferred At Point In Time PercentageOfRevenueFromProductsTransferredAtPointInTime	1	pure
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	47000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	247000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	322000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	842000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	888000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1091000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1257000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37245000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	44207000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12362000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6564000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24883000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37643000	USD
CY2020	us-gaap	Depreciation Depreciation	1900000	USD
CY2019	us-gaap	Depreciation Depreciation	3500000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	11700000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1794000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1794000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	975000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	795000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	819000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	999000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	179000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	179000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	179000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	135000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	70000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	77000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	819000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	716000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1197000	USD
CY2020Q4	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	0	USD
CY2019Q4	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	1034000	USD
CY2020Q4	aqms	Equipment Deposits Noncurrent EquipmentDepositsNoncurrent	258000	USD
CY2019Q4	aqms	Equipment Deposits Noncurrent EquipmentDepositsNoncurrent	254000	USD
CY2020Q4	aqms	Facility Closure Trust Deposit Noncurrent FacilityClosureTrustDepositNoncurrent	0	USD
CY2019Q4	aqms	Facility Closure Trust Deposit Noncurrent FacilityClosureTrustDepositNoncurrent	670000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	104000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	154000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1078000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3309000	USD
CY2020Q4	aqms	Accrued Property And Equipment Current AccruedPropertyAndEquipmentCurrent	715000	USD
CY2019Q4	aqms	Accrued Property And Equipment Current AccruedPropertyAndEquipmentCurrent	1146000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	479000	USD
CY2019Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1807000	USD
CY2020Q4	aqms	Use Tax Accrual Current UseTaxAccrualCurrent	1000	USD
CY2019Q4	aqms	Use Tax Accrual Current UseTaxAccrualCurrent	23000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	879000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	58000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	278000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1253000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4133000	USD
CY2017Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	700000	USD
CY2019	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	46000	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	29000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	296000	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	303000	USD
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	8404000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	29000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	88000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	88000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	89000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	38000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	332000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	433000	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	359000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	700000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1200000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	577000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0966	pure
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	642000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	624000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	577000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	661000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	227000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	888000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	52000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	20000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	533655
CY2020	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	691820
CY2020Q4	aqms	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	1.90
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.90
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	103500
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3569000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.89
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1387673
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4206000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	805749
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1694068
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.57
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	4500000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	3468296
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2197074
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.19
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2019	aqms	Sharebased Compensation Arrangement By Sharebased Payment Award Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardForfeited	564873
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	427450
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.46
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2402326
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3463692
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.71
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	7000000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	8056280
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	aqms	Sharebased Compensation Arrangement By Sharebased Payment Award Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardForfeited	2253925
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2076019
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.59
CY2020	aqms	Sharebased Compensation Arrangement By Sharebased Payment Award Issued To Fulfill Obligations For Separation Agreements SharebasedCompensationArrangementBySharebasedPaymentAwardIssuedToFulfillObligationsForSeparationAgreements	201101
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3398870
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1387673
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.89
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y11M23D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	434000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1068284
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.80
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P1Y10M6D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	400000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3300000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1387673
CY2020	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P1Y11M23D
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1068284
CY2020	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y10M6D
CY2020Q4	aqms	Sharebased Compensation Arrangement By Sharebased Payment Award Subject To Outstanding Options And Restricted Shares SharebasedCompensationArrangementBySharebasedPaymentAwardSubjectToOutstandingOptionsAndRestrictedShares	7011839
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3398870
CY2020Q4	aqms	Sharebased Compensation Arrangement By Sharebased Payment Award Officer And Director Purchase Plan SharebasedCompensationArrangementBySharebasedPaymentAwardOfficerAndDirectorPurchasePlan	237382
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	103500
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	10751591
CY2015Q3	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	21697	acre
CY2019Q1	us-gaap	Payments For Rent PaymentsForRent	1500000	USD
CY2018Q3	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	14016	acre
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	661000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	227000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	888000	USD
CY2020	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	600000	USD
CY2018Q2	aqms	Onetime Fee Payable OnetimeFeePayable	500000	USD
CY2019Q1	aqms	Onetime Fee Payable OnetimeFeePayable	500000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-25760000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-44793000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25760000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-44793000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0005	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0006	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0007	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1554	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1911	pure
CY2020	aqms	Effective Income Tax Rate Reconciliation Impairment Charge EffectiveIncomeTaxRateReconciliationImpairmentCharge	0	pure
CY2019	aqms	Effective Income Tax Rate Reconciliation Impairment Charge EffectiveIncomeTaxRateReconciliationImpairmentCharge	-0.0024	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.0566	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.0014	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0164	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0001	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25116000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	20049000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	553000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2744000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31692000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	26924000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30717000	USD
CY2020Q4	aqms	Deferred Tax Assets Capitalized Startup Costs DeferredTaxAssetsCapitalizedStartupCosts	3461000	USD
CY2019Q4	aqms	Deferred Tax Assets Capitalized Startup Costs DeferredTaxAssetsCapitalizedStartupCosts	3767000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	402000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	364000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2160000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26713000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	975000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	211000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	156000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	192000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	-0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	19000	USD
CY2020Q4	aqms	Deferred Tax Liabilities Beneficial Conversion Feature DeferredTaxLiabilitiesBeneficialConversionFeature	819000	USD
CY2019Q4	aqms	Deferred Tax Liabilities Beneficial Conversion Feature DeferredTaxLiabilitiesBeneficialConversionFeature	-0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	975000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	211000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4000000.0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	200000	USD
CY2020Q4	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	1479000	USD
CY2020	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	2946000	USD
CY2020Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	-0	USD
CY2020Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	-0	USD
CY2020Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	-0	USD
CY2020Q4	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	11741000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	11741000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	183000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	108000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1454000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1306000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1635000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1081000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5476000	USD
CY2020Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	242000	USD
CY2020Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	217000	USD
CY2020Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	210000	USD
CY2020Q4	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	358000	USD
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1027000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2385000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2245000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1656000	USD
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2712000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8998000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	4081000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	3768000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	3501000	USD
CY2020Q4	us-gaap	Costs And Expenses CostsAndExpenses	4151000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	15501000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4063000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3768000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3411000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4151000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-15393000	USD
CY2020Q1	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	-203000	USD
CY2020Q2	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	-52000	USD
CY2020Q3	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	1722000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	164000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	166000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	1107000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1620000	USD
CY2020Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	22000	USD
CY2020Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	3000	USD
CY2020Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	18000	USD
CY2020Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	5000	USD
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	48000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-364000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-213000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1574000	USD
CY2020Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11364000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	11858000	USD
CY2019Q4	us-gaap	Costs And Expenses CostsAndExpenses	10873000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	13620000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10367000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4427000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3981000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1837000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15515000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25760000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-4427000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-3983000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1837000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-15515000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25762000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	59582603
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60136374
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60998971
CY2020Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62136421
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60861450
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	437000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1483000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2361000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	593000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4874000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4681000	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7185000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8231000	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4702000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24799000	USD
CY2019Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	620000	USD
CY2019Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	338000	USD
CY2019Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	282000	USD
CY2019Q4	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	315000	USD
CY2019	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1555000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4016000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4335000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5107000	USD
CY2019Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5856000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-11708000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19314000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	9317000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-10501000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-11316000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-11270000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-44795000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	43514225
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	50757448
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	45668000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8880000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10375000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11259000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-10280000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-40794000	USD
CY2019Q1	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	0	USD
CY2019Q2	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	0	USD
CY2019Q3	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	0	USD
CY2019Q4	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	-792000	USD
CY2019	aqms	Insurance Recoveries Net Of Related Expenses InsuranceRecoveriesNetOfRelatedExpenses	-792000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	2889000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	203000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	142000	USD
CY2019Q4	us-gaap	Interest Expense InterestExpense	243000	USD
CY2019	us-gaap	Interest Expense InterestExpense	3477000	USD
CY2019Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	63000	USD
CY2019Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	77000	USD
CY2019Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	85000	USD
CY2019Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	45000	USD
CY2019	us-gaap	Interest And Other Income InterestAndOtherIncome	270000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2826000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-126000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-57000	USD
CY2019Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-990000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3999000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11706000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10501000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11316000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11270000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44793000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57053982
CY2019Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57523283
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52263885
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2019Q4	aqms	Area Of Land Damaged By Fire AreaOfLandDamagedByFire	30000

Files In Submission

Name	View Source	Status
0001437749-21-004116-index-headers.html	Edgar Link	pending
0001437749-21-004116-index.html	Edgar Link	pending
0001437749-21-004116.txt	Edgar Link	pending
0001437749-21-004116-xbrl.zip	Edgar Link	pending
aqms-20201231.xsd	Edgar Link	pending
aqms-20201231_cal.xml	Edgar Link	unprocessable
aqms-20201231_def.xml	Edgar Link	unprocessable
aqms-20201231_lab.xml	Edgar Link	unprocessable
aqms-20201231_pre.xml	Edgar Link	unprocessable
aqms20201001_10k.htm	Edgar Link	pending
aqms20201001_10k_htm.xml	Edgar Link	completed
ex_221253.htm	Edgar Link	pending
ex_221254.htm	Edgar Link	pending
ex_221255.htm	Edgar Link	pending
ex_221256.htm	Edgar Link	pending
ex_221257.htm	Edgar Link	pending
ex_229524.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
z01.jpg	Edgar Link	pending
z02.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AQMS
Aqua Metals, Inc. Stock $aqms

2020 Q4 Form 10-K Financial Statement

#000143774921004116 Filed on February 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQMS Aqua Metals, Inc. Stock $aqms

2020 Q4 Form 10-K Financial Statement

#000143774921004116 Filed on February 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQMS
Aqua Metals, Inc. Stock $aqms